fbpx
  • Panels
    • ePlex Panels
      • Respiratory
      • Blood Culture
    • XT-8 Panels
  • Systems
    • ePlex System
      • Software Solutions
      • Patient Safety
    • XT-8 System
  • Company
    • The GenMark Story
      • Management Team
      • Board of Directors
    • Careers
      • Opportunities
    • Investors
    • Newsroom
  • Education
    • Disease State
      • Sepsis
      • Respiratory Infections
      • Genetic Conditions
      • Hepatitis C
      • GI Infections
    • Technology
    • Resources
  • Support
    • Contact Us
    • FAQs
    • Safety Data Sheets (SDS)
    • Your Long-Term Partner
SELECT YOUR REGION:
  • International
    • United States
| CONTACT US | CUSTOMER RESOURCE CENTER
GenMark
  • Panels
    • ePlex Panels
      • Respiratory Pathogen Panels
      • Blood Culture
  • Systems
    • ePlex System
      • Software Solutions
      • Patient Safety
  • Company
    • The GenMark Story
      • Management Team
      • Board of Directors
    • Careers
      • Opportunities
    • Investors
    • Newsroom
  • Education
    • Disease State
      • Sepsis
      • Respiratory Infections
      • GI Infections
    • Technology
    • Resources
  • Support
    • Contact Us
    • FAQs
    • Safety Data Sheets (SDS)
    • Long-Term Partner

Improving patient care
with multiplex molecular diagnostics

 

Detection of variant SARS-CoV-2 strains on the ePlex RP2 Panel

 

 

Select your area of expertise

 

ePlex System

The True Sample-to-Answer Solution®

Eliminate unnecessary ED wait times and experience the benefits of rapid comprehensive testing with the ePlex Respiratory Pathogen Panel. Contact GenMark today to learn how we can help you prepare for this flu season with a no commitment evaluation program and special pricing on the ePlex RP Panel.

 

Learn More  Request a Demo

Detection of variant SARS-CoV-2 strains on the ePlex RP2 Panel

Learn More

GenMark Diagnostics Launches
New Website

Learn More

Major teaching hospital in Grenoble, France demonstrates that ePlex BCID results could have modified antimicrobial treatment in 45% of patients

Learn More

WEBINAR: The Big Picture of Rapid BCID: A Retrospective Clinical Analysis Building to a Prospective Clinical Trial

View On-Demand

ASM MICROBE: June 20-24
Virtual Meeting

Visit Site

ECCMID: July 9-12
Vienna, Austria

Visit Site

GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad, CA 92008

 

© Copyright 2021 GenMark Diagnostics, Inc.
All rights reserved.

 

info@genmarkdx.com
P: +1 760-448-4300
F: +1 760-448-4301

 

Legal | Privacy Policy

 

 

This website uses cookies to improve your experience. Read More. You can opt-out if you wish. Change settingsACCEPT REJECT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Popup Button